A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how the drug works.

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. “While not ...

A new study has uncovered a key mechanism that helps one of the deadliest brain cancers evade the immune system, according to ...

Glioblastoma claims the lives of 200,000 people each year globally. Despite decades of research and funding, survival rates remain low.

SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates could substantially improve for pancreatic cancer, one of the most stubbornly ...

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

Researchers are particularly encouraged by new data involving a personalized mRNA therapy developed by Moderna and Merck. Results presented this month showed the treatment reduced the risk of melanoma ...

Across the country, more families are dealing with breast cancer, prostate cancer, and other types of cancer than ever before. In recent years, it feels like we are hearing the "C-word" more than ever ...